Evidence map›Paper›PMID 28374955›Full record

ArticleJournal of clinical laboratory analysis2018

RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.

Carolina Bonet Bub, Maria Giselda Aravechia, Thiago Henrique Costa, José Mauro Kutner, Lilian Castilho

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Transfusion support for a woman withImmunohematology · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Carolina Bonet BubHemotherapy and Cellular Therapy Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.ORCID http://orcid.org/0000-0001-5103-4970
Maria Giselda AravechiaHemotherapy and Cellular Therapy Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Thiago Henrique CostaHemotherapy and Cellular Therapy Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
José Mauro KutnerHemotherapy and Cellular Therapy Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Lilian CastilhoHemotherapy and Cellular Therapy Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Hospital Israelita Albert Einstein · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA considerable number of RHD alleles responsible for weak and partial D phenotypes have been identified. Serologic determination of these phenotypes is often doubtful and makes genetic analysis of RHD gene highly desirable in transfusion recipients and pregnant women. We analyzed the RHD gene in a cohort of pregnant women with doubtful D phenotypes.

methodsRHD genotyping was performed on 104 cases with D typing discrepancies or with history of serologic weak D phenotype. Laboratory-developed DNA tests, RHD BeadChip (Bioarray Solutions, Immucor), and sequencing were used to identify the RHD alleles.

resultsMolecular analyses showed 23 of 104 (22%) pregnant women were RHD*weak D types 1, 2, or 3 and not at risk for anti-D. Fifty-one (49%) were RHD*weak partial 4.0, 6 RHD*weak D type 38 (6%), 1 RHD*weak D type 45 (1%), 1 RHD*weak D type 67 (1%), and potentially at risk for being alloimmunized and making anti-D. Partial D was identified in 22 of 104 (21%) patients and definitively at risk for anti-D. DISCUSSION: Appropriate classification of RhD phenotypes is recommended for correct indication of RhIG in pregnant women. However, the serologic distinction between RhD-negative and RhD-positive phenotypes is a difficult task in the case of D variants due to the variations in serologic testing. Our results show a great variability in RHD variant alleles in pregnant women from this population of high admixture. According to these results, 78% of these obstetric patients are at risk for anti-D and candidates for RhIG.

Indexed as

Blood Grouping and CrossmatchingCohort StudiesFemaleGenotypeGenotyping TechniquesHumansPolymerase Chain ReactionPregnancyRh-Hr Blood-Group SystemRh IsoimmunizationRho(D) Immune GlobulinRh-Hr Blood-Group SystemRHO(D) antibodyRho(D) antigenRho(D) Immune GlobulinD variantsgenetic counselingpartial Dpregnant womenRHD allelesweak D

Identifiers

PMID28374955
PMCPMC6816983
OpenAlexW2605308761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.